Evidence map›Paper›PMID 41878293›Full record

ArticleJournal of medical robotics research2026

A Semi-Automated Robotic Platform for Curvilinear Catheter Implantation in HDR Prostate and GYN Brachytherapy.

Joshua Kinder, Blayton Padasdao, Rex Imanaka, Mitchell Kamrava, Bardia Konh

Abstract read
In one paragraph

Article in Journal of medical robotics research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Joshua KinderDepartment of Mechanical Engineering, University of Hawaii at Manoa, Honolulu, HI.
Blayton PadasdaoDepartment of Mechanical Engineering, University of Hawaii at Manoa, Honolulu, HI.ORCID 0009-0002-2421-8859
Rex ImanakaDepartment of Mechanical Engineering, University of Hawaii at Manoa, Honolulu, HI.
Mitchell KamravaDepartment of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, CA.ORCID 0000-0003-1744-6271
Bardia KonhDepartment of Mechanical Engineering, University of Hawaii at Manoa, Honolulu, HI.ORCID 0000-0001-9700-8751

Funding

Smart Needle with Intelligent Robotic Control for Prostate BrachytherapyK25EB030562 · NIBIB · UNIVERSITY OF HAWAII AT MANOA · PI KONH, BARDIA · 2021 to 2024
$715k
NIBIB NIH HHS K25 EB030562
6 · The paper itself

Abstract

High-dose-rate (HDR) brachytherapy is an effective treatment for prostate and gynecologic cancers, yet current rigid catheter systems constrain trajectories to straight paths, limiting conformity to patient-specific anatomy and compromising dose distribution. To address this, we developed and preliminarily evaluated a semi-automated robotic platform for curvilinear catheter implantation. The system integrates (i) a handheld tendon-driven active needle manipulator with joystick-based control, (ii) an innovative template for initial angulation, and (iii) a novel gynecologic applicator incorporating concentric tube robotics for steerable tandem delivery. Patient-specific curvilinear trajectories were preplanned from anonymized MRI/CT datasets, and experimental evaluations were conducted in air and tissue-mimicking phantoms. The handheld manipulator achieved tip displacement errors below 2.89 mm in air and 2.22 mm in phantom, while the combined device-template system reproduced prostate curvilinear trajectories with root mean squared deviations (RMSDs) under 3.67 mm. Integration of the concentric tube robot with the gynecologic applicator achieved uterine trajectories with RMSDs below 1.17 mm. These results demonstrate, for the first time, the feasibility of semi-automated active needle manipulation and concentric tube-assisted applicator design for anatomically conformal HDR brachytherapy. This approach has the potential to improve catheter placement accuracy, enable patient-specific dose escalation, and reduce toxicity to organs at risk in both prostate and cervical cancer treatment.

Indexed as

active needlebrachytherapycancerconcentric tube

Identifiers

PMID41878293
PMCPMC13008369

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.